Search

Your search keyword '"Roberto Pontremoli"' showing total 298 results

Search Constraints

Start Over You searched for: Author "Roberto Pontremoli" Remove constraint Author: "Roberto Pontremoli"
298 results on '"Roberto Pontremoli"'

Search Results

1. Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney

2. Risk of Cardiovascular Events in Metabolically Healthy Overweight or Obese Adults: Role of LDL-Cholesterol in the Stratification of Risk

3. Serum Uric Acid, Hypertriglyceridemia, and Carotid Plaques: A Sub-Analysis of the URic Acid Right for Heart Health (URRAH) Study

4. Prognostic Value and Relative Cutoffs of Triglycerides Predicting Cardiovascular Outcome in a Large Regional‐Based Italian Database

5. Serum Uric Acid/Serum Creatinine Ratio and Cardiovascular Mortality in Diabetic Individuals—The Uric Acid Right for Heart Health (URRAH) Project

6. The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetesResearch in context

7. Lipoprotein(a) Modulates Carotid Atherosclerosis in Metabolic Syndrome

8. Serum Uric Acid Predicts All-Cause and Cardiovascular Mortality Independently of Hypertriglyceridemia in Cardiometabolic Patients without Established CV Disease: A Sub-Analysis of the URic acid Right for heArt Health (URRAH) Study

9. Serum Uric Acid and Kidney Disease Measures Independently Predict Cardiovascular and Total Mortality: The Uric Acid Right for Heart Health (URRAH) Project

10. Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes

11. Association of Hypertriglyceridemia with All‐Cause Mortality and Atherosclerotic Cardiovascular Events in a Low‐Risk Italian Population: The TG‐REAL Retrospective Cohort Analysis

12. Normoalbuminuric kidney impairment in patients with T1DM: insights from annals initiative

13. Diabetic kidney disease in the elderly: prevalence and clinical correlates

14. Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative

15. [The difficult management of patients with type 2 diabetes and renal disease: from diagnosis to treatment]

16. Five-Year Predictors of Insulin Initiation in People with Type 2 Diabetes under Real-Life Conditions

17. Resistant Hypertension, Time‐Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus

18. Metabolic syndrome, serum uric acid and renal risk in patients with T2D.

19. Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach

20. GLP-1 Receptor Agonists and Kidney Protection

22. Uric acid promotes apoptosis in human proximal tubule cells by oxidative stress and the activation of NADPH oxidase NOX 4.

23. Acido urico, spettatore o artefice dell'aumentato rischio cardiovascolare e renale?

24. Global Cardiovascular Risk Assessment in the Management of Primary Hypertension: The Role of the Kidney

26. Among biomarkers of neutrophil activity, matrix metalloproteinases 8 independently predicts remission of metabolic syndrome

27. Empagliflozin in Patients with Chronic Kidney Disease

29. Low GFR amplifies the association between coronary three-vessel disease and all-cause mortality

30. Hyperuricemia increases the risk of cardiovascular mortality associated with very high HdL-cholesterol level

31. Serum uric acid and left ventricular mass index independently predict cardiovascular mortality: The uric acid right for heart health (URRAH) project

32. Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients

33. Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both

34. Low eGFR and albuminuria independently predict all-cause mortality in high-risk subjects undergoing coronary arteriography

35. CHA2DS2‐VASc and R2CHA2DS2‐VASc scores predict mortality in high cardiovascular risk population

36. Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry

37. Non-Haemodynamic Mechanisms Underlying Hypertension-Associated Damage in Target Kidney Components

38. Long-term blood pressure behavior and progression to end-stage renal disease in patients with immunoglobulin A nephropathy: a single-center observational study in Italy

39. Atherogenic dyslipidemia and diabetic nephropathy

40. Management of dyslipidaemia in patients with chronic kidney disease: a position paper endorsed by the Italian Society of Nephrology

41. Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?

42. PROGNOSTIC CUTOFF OF TRIGLYCERIDES PREDICTING CARDIOVASCULAR OUTCOME IN A LARGE REGIONAL-BASED ITALIAN DATABASE

43. Impact of Diabetes Mellitus and Its Comorbidities on Elderly Patients Hospitalized in Internal Medicine Wards: Data from the RePoSi Registry

44. Expanding the therapy options for diabetic kidney disease

45. Relation between drug therapy-based comorbidity indices, Charlson's comorbidity index, polypharmacy and mortality in three samples of older adults

46. Serum uric acid levels threshold for mortality in diabetic individuals: The URic acid Right for heArt Health (URRAH) project

47. Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology

48. SERUM URIC ACID, LEFT VENTRICULAR MASS AND CARDIOVASCULAR DEATH. THE URIC ACID RIGHT FOR HEART HEALTH (URRAH) STUDY

49. Role of Uric Acid in Vascular Remodeling: Cytoskeleton Changes and Migration in VSMCs

50. Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?

Catalog

Books, media, physical & digital resources